Biodesix, Inc. Receives Patent for System That Validates Mass Spectrometer Performance
8/19/2013 9:26:29 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that the U.S. Patent & Trademark Office has granted the company a patent for a new method and system of validating the performance of matrix-assisted, laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometer machines.
Help employers find you! Check out all the jobs and post your resume.
comments powered by